← Leaderboards
Irwin H. Gelman
Mount Sinai School Of Medicine Of Nyu
$3,329,420
Attributed
$3,329,420
Total exposure
3
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $289.8K · FY2005–20$500K$375K$250K$125K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
Funding mix
By agency
NIH$3,329,420 · 3
By mechanism
R01$2,811,450 · 1
R21$417,970 · 1
R55$100,000 · 1
Top collaborators
No co-investigators on record.
Most similar at Mount Sinai School Of Medicine Of Nyu
Same institution · by research overlap
- Robert F Margolskee$16,803,321
- Ethan A Halm$11,848,852
- Oscar A Candia$7,854,421
- Albert L Siu$4,771,561
- Heidi Stuhlmann$10,748,844
Others in their field
Top investigators on “Protein Kinase C”
- Reynold Alexander Panettieri · Rutgers Biomedical And Health Sciences$27,676,727
- Lawrence D Longo · Loma Linda University$25,159,029
- Ehud Isacoff · University Of California Berkeley$23,916,000
- Daria Mochly-Rosen · Stanford University$21,332,970
- Susan S Taylor · University Of California, San Diego$18,698,588
- Thomas J. Kipps · University Of California San Diego$18,276,637
Research focus
Protein Kinase CCell LineEpitheliumTissuesTumorigenesisBasePathway InteractionsExcisionSite Directed MutagenesisLeadOncogenicMediatingOncogenesCellsSignal TransductionIn VitroTumorGrowthLaboratory MouseMalignant NeoplasmsCytoskeletal ProteinsNeoplastic ProcessMatrix Assisted Laser Desorption IonizationMitogens
Grant awards (14)
Drug susceptibilities in fusion oncogene-driven pediatric sarcomas$189,986
R21 · FY2020 · CA · contact PI
Drug susceptibilities in fusion oncogene-driven pediatric sarcomas$227,984
R21 · FY2019 · CA · contact PI
PKC/PKA Regulation in Prostate Cancer by SSeCKS/Gravin/AKAP12$286,785
R01 · FY2014 · CA · contact PI
PKC/PKA Regulation in Prostate Cancer by SSeCKS/Gravin/AKAP12$274,346
R01 · FY2013 · CA · contact PI
PKC/PKA Regulation in Prostate Cancer by SSeCKS/Gravin/AKAP12$288,173
R01 · FY2012 · CA · contact PI
PKC/PKA Regulation in Prostate Cancer by SSeCKS/Gravin/AKAP12$284,596
R01 · FY2011 · CA · contact PI
PKC/PKA Regulation in Prostate Cancer by SSeCKS/Gravin/AKAP12$289,818
R01 · FY2010 · CA · contact PI
PKC/PKA Regulation in Prostate Cancer by SSeCKS/Gravin$285,992
R01 · FY2006 · CA · contact PI
PKC/PKA Regulation in Prostate Cancer by SSeCKS/Gravin$289,187
R01 · FY2005 · CA
PKC/PKA Regulation in Prostate Cancer by SSeCKS/Gravin$285,606
R01 · FY2004 · CA
PKC/PKA Regulation in Prostate Cancer by SSeCKS/Gravin$262,528
R01 · FY2003 · CA
PKC/PKA Regulation in Prostate Cancer by SSeCKS/Gravin$133,892
R01 · FY2002 · CA
PKC/PKA Regulation in Prostate Cancer by SSeCKS/Gravin$130,527
R01 · FY2002 · CA
PKC/PKA in Prostate Cancer$100,000
R55 · FY2002 · CA